DRW Securities LLC Has $857,000 Stock Holdings in Danaher Co. (NYSE:DHR)

DRW Securities LLC boosted its stake in shares of Danaher Co. (NYSE:DHR) by 100.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,081 shares of the conglomerate’s stock after purchasing an additional 1,541 shares during the period. DRW Securities LLC’s holdings in Danaher were worth $857,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Benjamin Edwards Inc. raised its stake in Danaher by 1.8% in the second quarter. Benjamin Edwards Inc. now owns 2,153 shares of the conglomerate’s stock valued at $538,000 after buying an additional 38 shares during the period. Wedge Capital Management L L P NC raised its stake in Danaher by 3.2% in the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock valued at $342,000 after buying an additional 38 shares during the period. Patrick M Sweeney & Associates Inc. raised its stake in Danaher by 3.4% in the second quarter. Patrick M Sweeney & Associates Inc. now owns 1,230 shares of the conglomerate’s stock valued at $307,000 after buying an additional 40 shares during the period. Trust Co of Kansas raised its stake in Danaher by 4.1% in the second quarter. Trust Co of Kansas now owns 1,022 shares of the conglomerate’s stock valued at $255,000 after buying an additional 40 shares during the period. Finally, Abacus Planning Group Inc. raised its stake in Danaher by 0.7% in the second quarter. Abacus Planning Group Inc. now owns 5,439 shares of the conglomerate’s stock valued at $1,359,000 after buying an additional 40 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Up 0.8 %

Shares of DHR stock opened at $237.65 on Tuesday. The stock’s fifty day moving average price is $257.38 and its two-hundred day moving average price is $259.93. The company has a market cap of $171.65 billion, a PE ratio of 45.35, a P/E/G ratio of 4.34 and a beta of 0.85. Danaher Co. has a fifty-two week low of $215.68 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company’s revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the business posted $2.02 EPS. Equities analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio is presently 20.61%.

Wall Street Analyst Weigh In

Several analysts have issued reports on DHR shares. KeyCorp upped their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Raymond James lowered their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. UBS Group lowered their target price on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Wells Fargo & Company initiated coverage on Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 target price on the stock. Finally, TD Cowen increased their target price on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.